髋膝关节骨关节炎临床指南推荐意见的横断面分析
该横断面分析比较了17部髋或膝骨关节炎临床指南的推荐意见及证据等级。指南在非手术多模式治疗上总体一致,但部分推荐模糊且证据水平差异大;药物和辅助器具推荐存在分歧,手术转诊时机均未明确。
要点
- 非手术多模式治疗(患者教育、运动、肥胖者减重)获指南普遍认同。
- 口服非甾体抗炎药是疼痛管理主要药物,2017年后指南对扑热息痛和强阿片更谨慎。
- 手术主要指征为严重持续疼痛和非手术治疗后功能丧失,但无指南定义最短保守治疗时间。
核心结论
- 髋或膝骨关节炎治疗推荐意见的证据和强度差异广泛,手术转诊时机仍不明确。
研究设计与样本
- 横断面分析,检索MEDLINE、Embase、Cochrane图书馆及专业学会网站(2020年6月),筛选461篇摘要后纳入31篇出版物(17部指南,来自10个专业学会)。
主要发现
- 17部指南中6部(35%)为高质量,10部(59%)为中等质量,1部(6%)为低质量;2017年后发布的指南质量良好。
- 药物推荐中口服非甾体抗炎药是疼痛管理主要手段;2017年后指南对扑热息痛和强阿片的使用推荐更谨慎。
- 对硫酸软骨素、氨基葡萄糖和关节腔内透明质酸注射的推荐存在分歧。
- 对鞋垫、支具和经皮电刺激的推荐相互矛盾。
关键数值与推荐
- 指南质量采用AGREE II工具评估,证据等级和推荐强度标准化为GRADE标准。
- 髋/膝关节置换的主要指征为严重持续疼痛和非手术治疗后功能丧失。
- 无指南定义术前最短保守治疗时间。
临床怎么用
- 临床可依据多数指南共识,对髋或膝骨关节炎患者采用包含患者教育、运动和肥胖者减重的非手术多模式治疗。
- 疼痛管理可以口服非甾体抗炎药为主,参考2017年后指南对扑热息痛和强阿片持更谨慎态度。
- 对硫酸软骨素、氨基葡萄糖、关节腔内透明质酸注射、鞋垫、支具和经皮电刺激等推荐存在分歧,临床决策需结合具体情况。
- 手术转诊时机缺乏指南明确的最短保守治疗时间定义,需个体化判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare guideline recommendations for hip and knee osteoarthritis (OA) and their level of evidence. DATA SOURCES: MEDLINE, Embase, the Cochrane Library, and websites of professional societies were searched in June 2020 using keywords such as knee or hip osteoarthritis, degenerative arthritis, guideline, and practice guideline. STUDY SELECTION: General treatment guidelines for OA of the hip or knee published in English. After 461 abstracts were screened, 31 publications (17 guidelines from 10 professional societies) were included for analysis. DATA EXTRACTION: Three reviewers assessed the quality of the guidelines according to the Appraisal of Guidelines for Research and Evaluation II tool. The rating of evidence and strength of recommendation was extracted and standardized into the Grading of Recommendations Assessment, Development, and Evaluation criteria. DATA SYNTHESIS: Of the 17 guidelines included, 6 (35%) were of high quality, 10 (59%) of moderate quality, and 1 (6%) of low quality. Guidelines published after 2017 were of good quality. Although guidelines generally agreed on a nonsurgical multimodal concept, including patient education, exercise, and weight loss in obese, some recommendations remained vague and the level of evidence varied widely. In pharmacologic treatment, oral nonsteroidal anti-inflammatory drugs were the mainstay for pain management. Guidelines published after 2017 were more cautious in their recommendation for the use of paracetamol and strong opioids. Disagreement was observed for chondroitin sulfate, glucosamine, and intra-articular hyaluronic acid injections. Recommendations were conflicting for the use of insoles, braces, and transcutaneous electrical stimulation. The main indications for hip/knee arthroplasty were severe, persisting pain and loss of function despite nonsurgical treatment. No guideline defined a minimum time of conservative treatment before surgery. CONCLUSIONS: We found a wide variation in evidence and strength of recommendations for OA treatment. Recommendations on when to refer patients for surgery remained unclear.
引用
- Bichsel D, Liechti FD, Schlapbach JM, et al. Cross-sectional Analysis of Recommendations for the Treatment of Hip and Knee Osteoarthritis in Clinical Guidelines. Arch Phys Med Rehabil. 2021. PMID: 34411512. doi:10.1016/j.apmr.2021.07.801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。